Font Size: a A A
Keyword [KRas]
Result: 41 - 60 | Page: 3 of 10
41. Screen KRAS Mutations From Plasma Of Cancer Patients
42. Clinical Significance Of PD-L1 Expression In Human Non-small-cell Lung Cancer And The Study Of Its Biological Function
43. The Association Between Clinicopathological Characteristics, Prognosis And Molecular Phenotype In Pulmonary Mucin Producing Adenocarcinoma
44. The Study Of Molecular Markers In Colorectal Neoplasms And Accurate Stratification On Colorectal Cancer
45. Clinical Characteristics And Prognosis Significance Of Driver Oncogenes In Chinese Lung Adenocarcinoma
46. Studies On The Establishment And Clinical Application Of Detection For Free DNA KRAS Mutation In The Peripheral Blood
47. Detection EMl4-ALK Fusion Genes And Analysis Its Clinical Features In Nsclc Patients Possesing Clinical Characteristics Related To Egfr Mutations
48. Kras Gene Detection By Combination Of LDR And Taqman
49. The Detection Method Of EGFR/KRAS Gene Mutations In Pleural Effusions Of NSCLC Patients And The Clinical Implication
50. Clinical Significance Of Detection Of Plasma-Based EGFR And KRAS Mutations In Patients With Advanced NSCLC
51. Analysis Of Oncogenic Driver Mutations In Lung Squamous-Cell Carcinoma From Chinese Population
52. Sequence Analysis Of EGFR, MET, KRAS And BRAF Genes’ Hotspot Mutation In Gastric Cancer
53. Establishment Of High Resolution Melting Analysis For Detecting KRAS And BRAF Gene Mutations In Colorectal Cancer And Lung Cancer
54. The Study Of Related Gene Mutation Condition And Abnormal Expression Of RASA1in Pancreatic Cancer
55. The Correlation Analysis Between The Short-term Efficacy Of Postoperative Adjuvant Chemotherapy For Non-Small Cell Lung Cancer And Driver Gene EGFR、KRAS And Resistance Protein ERCC1、RRM1
56. Mir - 181 - C Gene Methylation In Gastric Cancer Tissue
57. Comparison Of KRAS Mutational Analysis Detected Between Plasma And Tissue In NSCLC
58. Detection Of KRAS Gene Mutations In Peripheral Blood And Tumor Tissues Of Patients With Pancreatic Cancer
59. The Study Of EGFR、KRas Protein Expression And Mutations Of EGFR Extracellular Domain IV In Epidermal Ovarian Carcinoma
60. Malignant Potential Mechanisms And EGFR、KRAS Mutation In Pulmonary Micropapillary Adenocarcinoma
  <<First  <Prev  Next>  Last>>  Jump to